MedPath

Diagnostic accuracy and feasibility of a rapid SARS-CoV-2 (COVID-19) antigen test in general practice – a prospective multicenter validation and implementation study.

Phase 3
Conditions
COVID-19SARS-CoV-19 infection
U07.1
COVID-19, virus identified
Registration Number
DRKS00023822
Lead Sponsor
niversitätsklinikum Würzburg Institut für Allgemeinmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
1518
Inclusion Criteria

respiratory symptoms (e.g. acute bronchitis or pneumonia, respiratory distress or fever)
- Acute hypo- or anosmia or hypo- or ageusia

Exclusion Criteria

symptomatic and asymptomatic patients in a nursing home, asymptomatic patients whose testing is done for follow-up reasons (travel history, contact person, etc.)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
-Validation of sensitivity, specificity, positive predictive value, negative predictive value of a rapid SARS-CoV-2 antigen tests in daily clinical routine
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath